Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MYTHOS: Furosemide and Matched Hydration for CIN Prevention
NCT00702728Phase 3Unknown
- Sponsor
- Centro Cardiologico Monzino
- Start
- Jun 2008
- Primary completion
- Jun 2009
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of furosemide in contrast-induced nephropathy (CIN), sponsored by Centro Cardiologico Monzino. Primary endpoint: Incidence of Contrast Induced Nephropathy. Status: unknown.
02
Drugs
furosemide
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT00702728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00702728.